Leaflet IMURAN 50mg film-coated tablets

Indicated for: immunosuppression

Route of administration: oral

Substance: azathioprine (immunosuppressant)

ATC: L04AX01 (Antineoplastic and immunomodulating agents | Immunosuppressants | Other immunosuppressants)

Precautions:
Avoid live vaccines
Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Immunosuppression / infection risk
Immunosuppression / infection risk

This medicine may increase the risk of infections.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Myelosuppression / agranulocytosis
Myelosuppression / agranulocytosis

This medicine may lower blood cell counts.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Genetic test recommended
Genetic test recommended

A genetic test may be needed before treatment.

Azathioprine is an immunosuppressive agent used in the treatment of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel diseases (Crohn's disease and ulcerative colitis). It is also used to prevent organ rejection following transplants, particularly kidney transplants.

Azathioprine works by inhibiting purine synthesis, reducing the proliferation of T and B lymphocytes, and suppressing the immune response. It is administered orally or intravenously, with the dose adjusted based on body weight and patient response.

Common side effects include nausea, vomiting, diarrhea, and bone marrow suppression, which can lead to anemia, leukopenia, and thrombocytopenia. In rare cases, severe adverse reactions such as hepatotoxicity, pancreatitis, or an increased risk of infections and malignancies may occur. Regular monitoring of hematological and hepatic parameters is essential during treatment.

Azathioprine is an effective therapeutic option for managing autoimmune diseases and preventing organ rejection, contributing to improved quality of life for patients.

General data about IMURAN 50mg

  • Substance: azathioprine
  • Date of latest medicines list: 01-06-2026
  • Product code: W60846001
  • Concentration: 50mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 100
  • Product type: Original
  • Price: 67.06 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: EXCELLA GMBH & CO. KG - GERMANIA
  • Holder: ASPEN PHARMA TRADING LIMITED - IRLANDA
  • Number: 10042/2017/01
  • Shelf life: 5 years

Concentrations available for azathioprine

  • 100mg
  • 25mg
  • 50mg
  • 75mg

Compensation lists for IMURAN 50mg Aspen

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

67.06 RON

33.53 RON

33.53 RON

G13 (C1) - Myasthenia gravis

Price

Copayment

Patient

67.06 RON

67.06 RON

0.00 RON

G14 (C1) - Multiple sclerosis

Price

Copayment

Patient

67.06 RON

67.06 RON

0.00 RON

G17 (C1) - Major collagenosis (systemic lupus erythematosus, scleroderma)

Price

Copayment

Patient

67.06 RON

67.06 RON

0.00 RON

G18 (C1) - Rheumatoid arthritis, psoriatic arthropathy, severe chronic psoriasis and juvenile arthritis

Price

Copayment

Patient

67.06 RON

67.06 RON

0.00 RON

G25 (C1) - Chronic renal failure

Price

Copayment

Patient

67.06 RON

67.06 RON

0.00 RON

G27 (C1) - Pemphigus

Price

Copayment

Patient

67.06 RON

67.06 RON

0.00 RON

G5 (C1) - Autoimmune hepatitis

Price

Copayment

Patient

67.06 RON

67.06 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

67.06 RON

67.06 RON

0.00 RON

NHP 4.A (C2) - Multiple sclerosis

Price

Copayment

Patient

67.06 RON

67.06 RON

0.00 RON

NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant

Price

Copayment

Patient

67.06 RON

67.06 RON

0.00 RON

NHP 9.6 (C2) - Lung transplant

Price

Copayment

Patient

67.06 RON

67.06 RON

0.00 RON

NHP 9.7 (C2) - Outpatient treatment of transplant patients

Price

Copayment

Patient

67.06 RON

67.06 RON

0.00 RON